DuPont de Nemours, Inc.'s Stock Analysis

DuPont Announces Reverse Stock Split and Shareholder Voting Results

DuPont de Nemours, Inc. held its Annual Meeting of Stockholders on May 21, 2026, where 83.27% of the outstanding shares were voted. Stockholders elected 10 nominees to the Board of Directors, approved executive compensation, and ratified the appointment of PricewaterhouseCoopers LLP as the independent accounting firm for 2026. A significant resolution was the approval of a reverse stock split at a ratio of 1-for-3, which is set to take effect on June 24, 2026, reducing the total number of authorized shares from approximately 1.67 billion to about 555 million.

The reverse stock split will consolidate three shares into one and will not change stockholders' proportional ownership, though adjustments will be made for fractional shares. DuPont reaffirmed its financial guidance for the second quarter and full year 2026, indicating that earnings per share metrics will be reported on a split-adjusted basis. The company expects to maintain a weighted average diluted share count of approximately 137 million shares for its financial reporting following the reverse stock split.

May 26, 2026 16:19:37

DuPont Reports First Quarter 2026 Financial Results and Guidance

DuPont de Nemours, Inc. reported net sales of $1.7 billion for the first quarter of 2026, reflecting a 4% increase compared to the previous year, driven by a 2% rise in organic sales. The company achieved a GAAP income from continuing operations of $150 million and an adjusted EPS of $0.55. Cash flow from operating activities was $232 million, with transaction-adjusted free cash flow of $147 million. The company also completed the divestiture of its Aramids business on April 1, 2026, for approximately $1.2 billion in cash and equity interests, and announced a $275 million accelerated share repurchase program set to launch soon.

In light of its strong performance, DuPont raised its full-year financial guidance, anticipating net sales of about $1.8 billion for the second quarter and estimating adjusted EPS of approximately $0.59. The company expects organic sales growth of around 3%, with a slight benefit from currency fluctuations. DuPont's strategic focus remains on value creation through customer service, operational excellence, and prudent capital allocation.

May 05, 2026 06:08:04

DuPont Board Size Reduced Following Director Resignation

Luke Kissam resigned from the Board of Directors of DuPont de Nemours, effective April 14, 2026, due to his upcoming role as Chief Executive Officer of Corteva, Inc. His departure was not due to any disagreements with the company regarding its operations or policies.

Following Mr. Kissam's resignation, DuPont's Board of Directors will reduce its size from eleven members to ten. This change reflects the adjustment in leadership following the departure of Mr. Kissam.

Apr 15, 2026 16:14:11

DuPont Plans Reverse Stock Split Subject to Shareholder Approval

DuPont de Nemours, Inc. announced plans to seek shareholder approval for a reverse stock split of its common stock, with a proposed ratio of not less than 1-for-2 and not more than 1-for-4. The decision on the exact ratio will be made by the Board of Directors. The company has scheduled an Annual Meeting of Stockholders on May 21, 2026, with a record date of March 30, 2026, for stockholders entitled to vote on this proposal.

If approved, the reverse stock split will also lead to a corresponding reduction in the number of authorized shares of common stock. This action is not expected to affect the voting rights of stockholders or the company's business operations. DuPont plans to file a preliminary proxy statement with the SEC, and stockholders are encouraged to review this and other relevant documents when available.

Mar 18, 2026 17:18:13

DuPont Plans Sale of Aramids Business to Arclin by 2026

DuPont de Nemours, Inc. expects to finalize the sale of its aramids business, which includes Kevlar® and Nomex®, to Arclin on April 1, 2026. All regulatory conditions required for the transaction were met as of March 10, 2026.

The company has acknowledged the inherent uncertainties involved in the transaction and the potential impacts on its financial performance. Factors that may affect the completion of the sale and its future implications include the fulfillment of conditions, unforeseen liabilities, and operational challenges. Investors should consider these risks as they may influence DuPont's financial condition and operational results.

Mar 16, 2026 16:34:56

DuPont Reports Fourth Quarter and Full Year 2025 Results

DuPont de Nemours, Inc. announced its financial results for the fourth quarter and full year of 2025, revealing flat net sales of $1.7 billion for the fourth quarter and a 2% increase in full year net sales to $6.8 billion. The company reported a GAAP loss of $108 million for the fourth quarter, with an adjusted EPS of $0.46. Cash provided by operating activities for the fourth quarter was $87 million, leading to a transaction-adjusted free cash flow of $228 million. The company also initiated guidance for 2026, projecting about 3% organic growth for the year.

In the Healthcare & Water Technologies segment, net sales grew by 4% in the fourth quarter, while the Diversified Industrials segment saw a 3% decline in net sales. For the full year, Healthcare & Water Technologies achieved a 9% increase in net sales, driven by strong performance in medical packaging and industrial water markets. In contrast, the Diversified Industrials segment experienced a 3% decrease, primarily due to ongoing weakness in construction markets. The company completed the separation of its Electronics business, which will now be reported as discontinued operations.

Feb 10, 2026 06:06:47

DuPont Appoints D.G. Macpherson to Board of Directors

DuPont de Nemours, Inc. has appointed D.G. Macpherson to its Board of Directors, effective January 20, 2026. Mr. Macpherson, who is recognized as an independent director, brings extensive experience from his role as Chief Executive Officer of W.W. Grainger, Inc. His background includes leadership in operational excellence, supply chain optimization, and business transformation, which DuPont aims to leverage in its growth strategy. He holds a bachelor’s degree from Stanford University and an MBA from Northwestern’s Kellogg School of Management.

Mr. Macpherson’s appointment follows a rigorous selection process, with no prior arrangements influencing his selection. He will receive standard compensation for non-employee directors. His previous roles include serving as Chief Operating Officer at Grainger and a Partner at Boston Consulting Group, providing him with a robust foundation in corporate strategy and continuous improvement methodologies. His presence on the board is expected to contribute to DuPont's efforts in delivering long-term value to shareholders and enhancing its operational capabilities.

Jan 20, 2026 17:00:08

DuPont Sets Minimum EBITDA Following Qnity Spin-Off Agreement

DuPont de Nemours, Inc. announced that its Applicable Percentage following the spin-off of Qnity Electronics, Inc. is 56%. This percentage was established in accordance with the Separation and Distribution Agreement dated November 1, 2025.

As a result of this agreement, DuPont's Minimum EBITDA is recalibrated to $1.4 billion. The Applicable Percentage for Qnity Electronics is set at 44%, reflecting the division of financial metrics between the two companies.

Dec 04, 2025 16:42:35

DuPont Completes Consent Solicitations and Tender Offer for Notes

DuPont de Nemours, Inc. has successfully completed its consent solicitations for amendments to the indentures governing its 5.319% Notes due 2038 and 5.419% Notes due 2048, receiving the required consents by the expiration date of November 7, 2025. The supplemental indenture reflecting these amendments became effective on November 19, 2025. Additionally, DuPont announced the early results of its tender offer to purchase up to $739,256,000 of the 2048 Notes, with valid tenders exceeding the maximum amount, leading to a prorated acceptance of the notes. Payments for the accepted notes are scheduled for November 19, 2025, with the tender offer set to expire on December 3, 2025.

Following the completion of these financial maneuvers, DuPont aims to enhance its capital structure post-Electronics separation by repaying approximately $4.0 billion of its senior notes. This includes repayment of various notes due in 2025, 2028, and 2038. The company’s actions are part of its broader strategy to manage its debt obligations effectively and streamline its financial commitments.

Nov 19, 2025 16:21:47

DuPont Reports Q3 2025 Results and Shareholder Returns

DuPont de Nemours, Inc. reported third quarter 2025 net sales of $3.1 billion, reflecting a 7% increase compared to the same period last year, driven by a 6% rise in organic sales. The company achieved a GAAP income from continuing operations of $308 million and adjusted earnings per share (EPS) of $1.09. Operating EBITDA reached $840 million, with cash provided by operating activities amounting to $591 million. DuPont raised its full-year operating EBITDA guidance to $1.6 billion, highlighting ongoing strength in electronics, healthcare, and water markets.

In a move to return value to shareholders, DuPont's Board of Directors approved a new share repurchase authorization of up to $2 billion and announced a $500 million accelerated share repurchase program. Additionally, the company declared a quarterly dividend of $0.20 per share, aligning with its targeted payout ratio. The results reflect the company's operational improvements and strategic focus following the separation of its Electronics business, which is now reported as discontinued operations.

Nov 06, 2025 06:05:02